1. Cholera toxin and GMI: a model membrane study with IAsys. (February 1999) Authors: Athanassopoulou, N.; Davies, R. J.; Edwards, P. R.; Yeung, D.; Maule, C. H. Journal: Biochemical Society transactions Issue: Volume 27:Number 2(1999) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of a golden beam data set for the commissioning of a proton double‐scattering system in a pencil‐beam dose calculation algorithm. Issue 9 (25th August 2014) Authors: Slopsema, R. L.; Lin, L.; Flampouri, S.; Yeung, D.; Li, Z.; McDonough, J. E.; Palta, J. Journal: Medical physics Issue: Volume 41:Issue 9(2014) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease. Issue 1 (18th December 2013) Authors: Slopsema, R. L.; Mamalui, M.; Zhao, T.; Yeung, D.; Malyapa, R.; Li, Z. Journal: Medical physics Issue: Volume 41:Issue 1(2014) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hepatosplenic T‐cell lymphoma, immunosuppressive agents and biologicals: what are the risks?. Issue 3 (March 2014) Authors: Subramaniam, K.; Yeung, D.; Grimpen, F.; Joseph, J.; Fay, K.; Buckland, M.; Talaulikar, D.; Elijah, J.; Clarke, A. C.; Pavli, P.; Moore, J. Journal: Internal medicine journal Issue: Volume 44:Issue 3(2014) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P333: MULTI-COHORT GENE EXPRESSION RESOURCE FOR AUTOMATIC SUBTYPING OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022) Authors: Mäkinen, V.-P.; Rehn, J.; Breen, J.; Yeung, D.; White, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12 DIRECT STUDY BASED ON TROUGH LEVELS MINIMISE TOXICITY AND PRESERVE EFFICACY. (23rd June 2022) Authors: Yeung, D.; Grigg, A.; Shanmuganathan, N.; Soltenbeck, A.; White, D.; Branford, S.; Viiala, N.; Rowlings, P.; Mills, A.; Shortt, J.; Tiley, C.; Ross, D.; Kipp, D.; Harrup, R.; Cunningham, I.; Kwan, J.; Eek, R.; Mutsando, H.; Tan, K.-S.; Burbury, K. Other Names: other. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PB2176: AN AUSTRALIAN/NEW ZEALAND RANDOMIZED TRIAL OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN MATCHED RELATED PERIPHERAL BLOOD STEM CELL TRANSPLANTS FOR ACUTE LEUKAEMIA OR MYELODYSPLASIA – ALLG BM12. (23rd June 2022) Authors: Curtis, D.; Patil, S.; Purtill, D.; Ritchie, D.; Yeung, D.; Lewis, C.; Wong, E.; Moore, J.; Perera, T.; King, M.; De Abreu Lourenco, R.; Morrissey, O.; Hill, G.; Reynolds, J.; Tey, S.; Gottlieb, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗